UK to review how financial regulators work together: Hammond

LONDON (Reuters) - British finance minister Philip Hammond said he would launch a review into how the country's financial regulators work together as part of a push to ensure the competitiveness of the sector as Britain leaves the European Union. 'We must maintain our reputation not only as one of the most dynamic and innovative places to do business – but one of the most resilient and agile too,' Hammond said in excerpts of a speech he was due to deliver later on Thursday. Britain's finance ministry said it was responding to calls from businesses to coordinate the roll-out of new rules and to manage the impact of regulatory change from different agencies

Reuters June 21, 2019 00:05:07 IST
UK to review how financial regulators work together: Hammond

UK to review how financial regulators work together Hammond

LONDON (Reuters) - British finance minister Philip Hammond said he would launch a review into how the country's financial regulators work together as part of a push to ensure the competitiveness of the sector as Britain leaves the European Union.

"We must maintain our reputation not only as one of the most dynamic and innovative places to do business – but one of the most resilient and agile too," Hammond said in excerpts of a speech he was due to deliver later on Thursday.

Britain's finance ministry said it was responding to calls from businesses to coordinate the roll-out of new rules and to manage the impact of regulatory change from different agencies.

(Writing by William Schomberg; editing by Stephen Addison)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Business

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.